Workflow
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Medusind, Inc. Customers Whose Data May Have Been Compromised
GlobeNewswire· 2025-01-08 22:18
NEWTOWN, Pa., Jan. 08, 2025 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by Medusind, Inc. Medusind learned of suspicious activity on its computer network on or about December 29, 2023. To join this case, go HERE. About Medusind, Inc. Medusind is a healthcare organization specializing in revenue cycle management (RCM) solutions tailored for medical and dental practices. What happened? On or around December 29, 2023, Medusind detected sus ...
AngioDynamics: A Surgical Approach To Market Growth
Seeking Alpha· 2025-01-08 22:15
AngioDynamics, Inc. (NASDAQ: ANGO ) designs and manufactures medical devices for oncology, vascular access, and peripheral vascular diseases; recently, though, they've taken a strategic turn toward Med Tech-specifically mechanical thrombectomy and targeted cancer therapy. These markets, it seems, are where the promise of higher profits andThe mission of Grassroots Trading rests on the following principles: providing objective, unbiased, and balanced research, backed by solid data and completely void of emot ...
Why Uber Technologies Stock Was a Dog in December
The Motley Fool· 2025-01-08 22:15
A retreat in the development of autonomous vehicles was the major news item decelerating the stock of rideshare incumbent Uber Technologies (UBER -1.88%) in December. As a result, the shares skidded to a more than 16% loss in value over the month.Robotaxi retreatThat news came from storied U.S. auto manufacturer General Motors on Dec. 10 when it announced that it will no longer bankroll the development of a specialized robotaxi under its Cruise autonomous-driving division.In its official press release annou ...
Air Products' Board of Directors Issues Response to Mantle Ridge
Prnewswire· 2025-01-08 22:15
LEHIGH VALLEY, Pa., Jan. 8, 2025 /PRNewswire/ -- Air Products' (NYSE:APD) Board of Directors today issued the following statement in response to Mantle Ridge's Shareholder letter, issued today:Mantle Ridge is proposing that Air Products be controlled by Mantle Ridge's hand-picked candidates for CEO and Chairman. This should be troubling to all Air Products shareholders for the following reasons: Mantle Ridge Chairman nominee Dennis Reilley has not held a management position in 18 years and would be coming i ...
AM Best Upgrades the Financial Strength Ratings for Employers Holdings, Inc.'s Operating Subsidiaries to "A" (Excellent)
Newsfilter· 2025-01-08 22:15
RENO, Nev., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Employers Holdings, Inc. (NYSE:EIG), a leading provider of workers' compensation insurance, is pleased to announce that AM Best has upgraded the Financial Strength Rating (FSR) of each of its insurance companies to A (Excellent) from A- (Excellent) and their Long-Term Issuer Credit Ratings (Long-Term ICR) to "a" (Excellent) from "a-" (Excellent). Concurrently, AM Best has upgraded the Long-Term ICR of Employers Holdings, Inc. to "bbb" (Good) from "bbb-" (Good). ...
Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand
Newsfilter· 2025-01-08 22:15
TUSTIN, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) ("Avid" or the "Company"), a dedicated biologics contract development and manufacturing organization ("CDMO") working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today posted an investor presentation in connection with its pending transaction with GHO Capital Partners LLP ("GHO") and Ampersand Capital Partners ("Ampersand") on its ...
Mint Incorporation Limited Announces Pricing of $7 million Initial Public Offering and Listing on Nasdaq
GlobeNewswire· 2025-01-08 22:15
Hong Kong, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Mint Incorporation Limited (Nasdaq: MIMI) (the “Company”), a Hong Kong-based interior design and fit out works provider, today announced the pricing of its initial public offering (the “Offering”) of 1,750,000 Class A ordinary shares (the “Class A Ordinary Shares”), at a price of $4.00 per Class A Ordinary Share (the “Offering Price”). The Class A Ordinary Shares are expected to begin trading on the Nasdaq Capital Market on January 10, 2025 under the symbol “MIMI ...
AM Best Upgrades the Financial Strength Ratings for Employers Holdings, Inc.'s Operating Subsidiaries to “A” (Excellent)
GlobeNewswire News Room· 2025-01-08 22:15
RENO, Nev., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Employers Holdings, Inc. (NYSE:EIG), a leading provider of workers’ compensation insurance, is pleased to announce that AM Best has upgraded the Financial Strength Rating (FSR) of each of its insurance companies to A (Excellent) from A- (Excellent) and their Long-Term Issuer Credit Ratings (Long-Term ICR) to “a” (Excellent) from “a-” (Excellent). Concurrently, AM Best has upgraded the Long-Term ICR of Employers Holdings, Inc. to “bbb” (Good) from “bbb-” (Good). ...
Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand
GlobeNewswire· 2025-01-08 22:15
Avid Urges Stockholders to Vote FOR the Pending Transaction TODAYTUSTIN, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today posted an investor presentation in connection with its pending transaction with GHO Capital Partne ...
Frontier Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire· 2025-01-08 22:13
BOSTON and SOUTH SAN FRANCISCO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation (“Frontier” or the “Company”), a clinical-stage precision medicine company unlocking to advance transformational therapies, today announced that Chris Varma, Ph.D., Frontier’s co-founder, chairman, and CEO, will present a company overview at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025 at 11:30 a.m. PT. About Frontier Medicines Frontier Medicines is a clinical stage pre ...